BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/14/2026 10:05:05 AM | Browse: 7 | Download: 0
| Category |
Immunology |
| Manuscript Type |
Minireviews |
| Article Title |
Role of soluble human leukocyte antigen-G in virus-associated cancers: A focused minireview
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Abdellatif Bouayad |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Abdellatif Bouayad, Associate Professor, MD, Department of Immunology, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University, Hay al Hikma, Oujda 4867, Oriental, Morocco. abdellatifbouayad@hotmail.fr |
| Key Words |
Soluble human leukocyte antigen-G; Virus-associated cancers; Immune escape; Diagnostic biomarker; Prognostic biomarker; Immune evasion |
| Core Tip |
Increased soluble human leukocyte antigen-G (sHLA-G) levels are consistently associated with poor prognosis in hepatitis C virus/hepatitis B virus -related hepatocellular carcinoma and human papillomavirus-driven cervical cancer, underscoring its potential as a diagnostic and prognostic biomarker. High-risk human papillomavirus oncoproteins (E6 and E7) and hepatitis C virus proteins (core protein and nonstructural protein 3) may contribute to increased sHLA-G levels through cytokine-mediated immunosuppressive signalling pathways. The mechanisms by which sHLA-G-immunoglobulin-like transcript 2/immunoglobulin-like transcript 4 interactions modulate immune suppression in these virus-driven cancers remain incompletely understood. sHLA-G isoforms are primarily detected in plasma and other biological fluids using sandwich enzyme-linked immunosorbent assays, providing a reliable method for both clinical and research applications. |
| Citation |
Bouayad A. Role of soluble human leukocyte antigen-G in virus-associated cancers: A focused minireview. World J Virol 2026; In press |
 |
Received |
|
2026-02-13 01:52 |
 |
Peer-Review Started |
|
2026-02-13 01:52 |
 |
First Decision by Editorial Office Director |
|
2026-02-26 07:29 |
 |
Return for Revision |
|
2026-02-26 07:29 |
 |
Revised |
|
2026-03-08 11:25 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-04-14 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-04-14 10:05 |
 |
Articles in Press |
|
2026-04-14 10:05 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345